Z-Butylidenephthalide polymer wafer implant- Everfront Biotech

Drug Profile

Z-Butylidenephthalide polymer wafer implant- Everfront Biotech

Alternative Names: BP/polymer wafer; Cerebraca wafer; z-BP/polymer wafer

Latest Information Update: 11 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Everfront Biotech
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Axl receptor tyrosine kinase modulators; Immunomodulators; Nuclear receptor subfamily 4 group A member 1 modulators; Telomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Glioma

Most Recent Events

  • 01 Nov 2017 Phase-I/II clinical trials in Glioma (Recurrent, Adjuvant therapy) in Taiwan (Implant)
  • 02 Aug 2017 Everfront Biotech plans a phase I/IIa trial for Glioma (Adjuvant therapy, Recurrent) in USA (NCT03234595)
  • 02 Aug 2017 Everfront Biotech has patent pending for an angelica root extract for treating cancer in Hong Kong (Everfront Biotech website, August 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top